Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study
The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were asses...
21:109The Journal of Headache and Pain 2020
No hay comentarios:
Publicar un comentario